Oaktree Acquisition Corp. III Life Sciences (OACC) Competitors $10.56 +0.02 (+0.19%) As of 06/11/2025 03:54 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOwnershipSEC FilingsTrendsBuy This Stock OACC vs. NXRT, PAX, TINV, AC, ORC, NOAH, PLYM, AACT, GETY, and BRSPShould you be buying Oaktree Acquisition Corp. III Life Sciences stock or one of its competitors? The main competitors of Oaktree Acquisition Corp. III Life Sciences include NexPoint Residential Trust (NXRT), Patria Investments (PAX), Tiga Acquisition (TINV), Associated Capital Group (AC), Orchid Island Capital (ORC), Noah (NOAH), Plymouth Industrial REIT (PLYM), Ares Acquisition Co. II (AACT), Getty Images (GETY), and BrightSpire Capital (BRSP). These companies are all part of the "trading" industry. Oaktree Acquisition Corp. III Life Sciences vs. Its Competitors NexPoint Residential Trust Patria Investments Tiga Acquisition Associated Capital Group Orchid Island Capital Noah Plymouth Industrial REIT Ares Acquisition Co. II Getty Images BrightSpire Capital NexPoint Residential Trust (NYSE:NXRT) and Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, community ranking, profitability, risk, media sentiment, earnings and valuation. Does the MarketBeat Community prefer NXRT or OACC? NexPoint Residential Trust received 204 more outperform votes than Oaktree Acquisition Corp. III Life Sciences when rated by MarketBeat users. CompanyUnderperformOutperformNexPoint Residential TrustOutperform Votes20456.04% Underperform Votes16043.96% Oaktree Acquisition Corp. III Life SciencesN/AN/A Does the media refer more to NXRT or OACC? In the previous week, NexPoint Residential Trust and NexPoint Residential Trust both had 1 articles in the media. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.87 beat NexPoint Residential Trust's score of 1.33 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment NexPoint Residential Trust Positive Oaktree Acquisition Corp. III Life Sciences Very Positive Do analysts prefer NXRT or OACC? NexPoint Residential Trust presently has a consensus price target of $43.58, indicating a potential upside of 26.15%. Given NexPoint Residential Trust's stronger consensus rating and higher probable upside, analysts clearly believe NexPoint Residential Trust is more favorable than Oaktree Acquisition Corp. III Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NexPoint Residential Trust 0 Sell rating(s) 7 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Oaktree Acquisition Corp. III Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better earnings & valuation, NXRT or OACC? NexPoint Residential Trust has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNexPoint Residential Trust$255.34M3.42$44.26M-$1.28-26.99Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A Do institutionals & insiders hold more shares of NXRT or OACC? 76.6% of NexPoint Residential Trust shares are held by institutional investors. 15.4% of NexPoint Residential Trust shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is NXRT or OACC more profitable? NexPoint Residential Trust has a net margin of 17.54% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. NexPoint Residential Trust's return on equity of 9.54% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets NexPoint Residential Trust17.54% 9.54% 2.29% Oaktree Acquisition Corp. III Life Sciences N/A N/A N/A SummaryNexPoint Residential Trust beats Oaktree Acquisition Corp. III Life Sciences on 9 of the 10 factors compared between the two stocks. Get Oaktree Acquisition Corp. III Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for OACC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OACC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OACC vs. The Competition Export to ExcelMetricOaktree Acquisition Corp. III Life SciencesHolding Offices IndustryFinancial SectorNASDAQ ExchangeMarket Cap$236.81M$481.17M$5.69B$8.62BDividend YieldN/A7.70%4.13%4.18%P/E RatioN/A2.5312.7420.06Price / SalesN/A86.181,720.57157.10Price / CashN/A69.0149.9234.64Price / BookN/A6.492.854.70Net IncomeN/A$35.76M$1.23B$247.88M7 Day Performance0.38%2.35%0.98%2.66%1 Month Performance1.44%3.67%10.23%6.40%1 Year PerformanceN/A43.48%14.56%14.07% Oaktree Acquisition Corp. III Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OACCOaktree Acquisition Corp. III Life SciencesN/A$10.56+0.2%N/AN/A$236.81MN/A0.00N/APositive NewsNXRTNexPoint Residential Trust4.8562 of 5 stars$33.87+1.3%$43.58+28.7%-7.1%$856.35M$255.34M19.353PAXPatria Investments2.335 of 5 stars$13.43+1.2%$14.00+4.2%+11.0%$814.41M$374.20M26.86390Short Interest ↑TINVTiga AcquisitionN/A$23.26+1.0%N/A+151.6%$802.47MN/A0.00N/AHigh Trading VolumeACAssociated Capital Group2.1152 of 5 stars$37.85-0.2%N/A+10.4%$800.12M$12.29M18.2920Positive NewsORCOrchid Island Capital2.9461 of 5 stars$6.96+0.3%N/A-14.6%$757.99M$52.24M11.602,018News CoverageDividend AnnouncementShort Interest ↑NOAHNoah3.7482 of 5 stars$11.37+2.6%$12.00+5.6%+16.6%$752.00M$2.57B9.713,150Positive NewsPLYMPlymouth Industrial REIT3.3263 of 5 stars$16.22+1.9%$21.10+30.1%-20.8%$738.56M$193.70M810.7540AACTAres Acquisition Co. IIN/A$11.43+0.0%N/A+6.2%$706.75MN/A0.00N/AShort Interest ↓GETYGetty Images3.1604 of 5 stars$1.67+3.1%$4.35+160.5%-47.3%$690.41M$941.09M13.921,700Gap UpBRSPBrightSpire Capital2.9968 of 5 stars$5.22+2.7%$7.15+37.1%-8.0%$680.36M$329.49M-4.9750Positive News Related Companies and Tools Related Companies NexPoint Residential Trust Competitors Patria Investments Competitors Tiga Acquisition Competitors Associated Capital Group Competitors Orchid Island Capital Competitors Noah Competitors Plymouth Industrial REIT Competitors Ares Acquisition Co. II Competitors Getty Images Competitors BrightSpire Capital Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OACC) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. III Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition Corp. III Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OACC Stock Free OACC Stock Alerts